Advertisement

November 29, 2022

CROWN 2022 Second Interim Updates: When Will Be the Coronation of Lorlatinib?

  • Misako Nagasaka,
  • Sai-Hong Ignatius Ou
Published online: November 29, 2022

November 18, 2022

An IL-15 superagonist enables anti-tumor efficacy of NK cells against all molecular variants of small cell lung cancer (SCLC)

  • Kristen Fousek,
  • Lucas A. Horn,
  • Haiyan Qin,
  • ...
  • Anish Thomas,
  • Jeffrey Schlom,
  • Claudia Palena
Published online: November 18, 2022
Open Access

November 14, 2022

November 12, 2022

A clinician’s guide to bioinformatics for next-generation sequencing

  • Nicholas B. Larson,
  • Ann L. Oberg,
  • Alex A. Adjei,
  • Liguo Wang
Published online: November 12, 2022
Open Access

Expert consensus recommendations on biomarker testing in metastatic and non-metastatic non-small cell lung cancer in Asia

  • Tetsuya Mitsudomi,
  • Daniel Tan,
  • James Chih-Hsin Yang,
  • ...
  • Yi-Long Wu,
  • Pan-Chyr Yang,
  • Yasushi Yatabe
Published online: November 12, 2022

November 4, 2022

Robotic Esophagectomy Compared With Open Esophagectomy Reduces Sarcopenia within the First Postoperative Year: A Propensity Score-Matched Analysis

  • Felix Merboth,
  • Heiner Nebelung,
  • Natalie Wotschel,
  • ...
  • Marius Distler,
  • Jürgen Weitz,
  • Johanna Kirchberg
Published online: November 04, 2022

Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours: A Systematic Review

  • Conrad B. Falkson,
  • Emily T. Vella,
  • Peter M. Ellis,
  • Donna E. Maziak,
  • Yee C. Ung,
  • Edward Yu
Published online: November 04, 2022

October 28, 2022

MET alterations in NSCLC—Current Perspectives and Future Challenges

  • Jordi Remon,
  • Lizza E.L. Hendriks,
  • Giannis Mountzios,
  • ...
  • Gonzalo Recondo,
  • Guillermo Villacampa,
  • Martin Reck
Published online: October 28, 2022

October 24, 2022

A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)

  • Hyun Ae Jung,
  • Miso Kim,
  • Hae Su Kim,
  • ...
  • Jin Seok Ahn,
  • Keunchil Park,
  • Myung-Ju Ahn
Published online: October 24, 2022

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

  • Jair Bar,
  • Nir Peled,
  • Shiruyeh Schokrpur,
  • ...
  • Adrienne Bettini,
  • Simon Häfliger,
  • Alfredo Addeo
Published online: October 24, 2022
Open Access

October 22, 2022

Erratum

Published online: October 22, 2022

October 14, 2022

October 11, 2022

SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection

  • Qian Wang,
  • Zeynep H. Gümüş,
  • Cristina Colarossi,
  • ...
  • Xintong Wang,
  • Chung Yin Kong,
  • Paolo Boffetta
Published online: October 11, 2022

Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228

  • Paul K. Paik,
  • Pang-Dian Fan,
  • Besnik Qeriqi,
  • ...
  • Marc Ladanyi,
  • Elisa de Stanchina,
  • Charles M. Rudin
Published online: October 11, 2022

NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC

  • Gilberto de Castro Jr.,
  • Naiyer A. Rizvi,
  • Peter Schmid,
  • ...
  • Vikram Chand,
  • Tony Mok
  • for the NEPTUNE Investigators
Published online: October 11, 2022
Open Access

October 5, 2022

Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening

  • Matthew P. Smeltzer,
  • Wei Liao,
  • Nicholas R. Faris,
  • ...
  • Ayesha Mukhopadhyay,
  • Meredith A. Ray,
  • Raymond Uyiosa Osarogiagbon
Published online: October 05, 2022

September 30, 2022

September 29, 2022

Factors Associated With Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted Therapies

  • Ibiayi Dagogo-Jack,
  • Antonello Abbattista,
  • John F. Murphy,
  • ...
  • Elizabeth A. Krueger,
  • Holger Thurm,
  • Beow Y. Yeap
Published online: September 29, 2022
Open Access

September 28, 2022

September 18, 2022

Stage Shift Improves Lung Cancer Survival: Real-World Evidence

  • Ching-Yao Yang,
  • Yen-Ting Lin,
  • Li-Ju Lin,
  • ...
  • Jin-Yuan Shih,
  • Chong-Jen Yu,
  • Pan-Chyr Yang
Published online: September 18, 2022
Open Access

Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial

  • Matthew Craddock,
  • Ursula Nestle,
  • Jochem Koenig,
  • ...
  • Corinne Faivre-Finn,
  • Marcel van Herk,
  • Alan McWilliam
Published online: September 18, 2022
Open Access

August 29, 2022

Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817

  • Luis G. Paz-Ares,
  • Tudor-Eliade Ciuleanu,
  • Adam Pluzanski,
  • ...
  • Faith Nathan,
  • Nivedita Aanur,
  • Hossein Borghaei
Published online: August 29, 2022

November 3, 2021

Erratum

Published online: November 03, 2021

May 26, 2021

Erratum

Published online: May 26, 2021

May 9, 2021

Erratum

Published online: May 09, 2021

March 18, 2021

Erratum

Published online: March 18, 2021

February 1, 2021

Erratum

Published online: February 01, 2021

October 17, 2020

Erratum

Published online: October 17, 2020

October 16, 2020

Erratum

Published online: October 16, 2020

August 7, 2020

Erratum

Published online: August 07, 2020

June 29, 2020

Erratum

Published online: June 29, 2020

February 3, 2020

WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC

  • Max Backman,
  • Linnéa La Fleur,
  • Pinja Kurppa,
  • ...
  • Cecilia Lindskog,
  • Johan Botling,
  • Patrick Micke
Published online: February 03, 2020

August 26, 2018

WITHDRAWN: What is a “High-Impact” Journal?

  • Alex A. Adjei
Published online: August 26, 2018
Advertisement